959
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer

, , , , &
Pages 547-554 | Received 22 Aug 2010, Accepted 16 Nov 2010, Published online: 21 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lotte Sander, Niels Christian Langkilde, Mats Holmberg & Jesper Carl. (2014) MRI target delineation may reduce long-term toxicity after prostate radiotherapy. Acta Oncologica 53:6, pages 809-814.
Read now

Articles from other publishers (4)

Carrie A. Palm, Noah E. Canvasser & Willian T. N. Culp. (2021) Stenting of Malignant Urinary Tract Obstructions in Humans and Companion Animals. Veterinary Sciences 9:1, pages 13.
Crossref
Angela G M O'Neill, Suneil Jain, Alan R Hounsell & Joe M O'Sullivan. (2016) Fiducial marker guided prostate radiotherapy: a review. The British Journal of Radiology 89:1068, pages 20160296.
Crossref
Anne Sofie Korsager, Jesper Carl & Lasse Riis Østergaard. (2016) Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancer. Journal of Applied Clinical Medical Physics 17:3, pages 294-303.
Crossref
Anne Sofie Korsager, Jesper Carl & Lasse Riis Østergaard. (2013) MR-CT registration using a Ni-Ti prostate stent in image-guided radiotherapy of prostate cancer. Medical Physics 40:6Part1, pages 061907.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.